Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CHRNA9 agonists(cholinergic receptor nicotinic alpha 9 subunit agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H25N4O |
InChIKeyKYTXMUHHCFFFLJ-UHFFFAOYSA-O |
CAS Registry2920618-60-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Pain | Preclinical | US | 15 May 2024 |